Abstract:Background and aims. Osteopontin (OPN) is known to be associated with metastasis in many types of cancers. Since OPN is a highly phosphorylated and glycosylated protein, the modification after transcription is very important to its function. In hepatocellular carcinoma (HCC), the elevated expression of OPN at mRNA levels and its relationship with metastasis and poorer prognosis of-the patients have been reported. However, the prognostic impact of OPN at protein levels on the patients with hepatitis B virus (HBV)-related HCC after hepatectomy is still limited.Patients and methods. The expression of OPN was examined at protein level by using immunohistochemistry in 72 patients who underwent hepatectomy for HBV-related HCC, and its prognostic significance in disease-free and overall survival of the patients was also analyzed by log-rank test and multivariate Cox regression analyses.Results. Thirty-nine of 72 (54.17%) HBV-related HCC specimens were positive for OPN with cytoplasmic staining. OPN was highly expressed in the specimens with capsular infiltration compared to those without (P < 0.05), and also was significantly related with portal vein invasion (P < 0.01) and lymph node invasion (P < 0.01). The mean disease-free survival (DFS) was only 13.55 +/- 114.77 months when the HBV-related HCC specimens highly expressed OPN compared to 36,00 +/- 18.68 months for those with low expression (P < 0.001). The overall survival (OS) of the patients was 18.63 +/- 17.28 months when the HCC over-expressed OPN compared to 42.59 +/- 16.85 months for HCC with the low expressed OPN (P < 0.001). Multivariate analysis showed that OPN over-expression was the strongest independent adverse prognostic factor for both DFS (P = 0.01) and OS (P = 0.014).Conclusions. OPN over-expression was closely related to capsular infiltration, venous invasion, lymph node metastasis, and also with worse prognosis, suggesting that OPN might be deemed as a useful molecular marker for predicting the prognosis of HCC. (c) 2006 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.

[Expression of Osteopontin in the Pericystic Layer of Hepatic Hydatid Cyst].

The Expression and Clinical Relevation of Osteopontin and IL-17 in Severe Hepatitis B

Circulating osteopontin per tumor volume as a prognostic biomarker for resectable intrahepatic cholangiocarcinoma

Osteopontin Affects the Persistence of Beta-Glucan-induced Hepatic Granuloma Formation and Tissue Injury Through Two Distinct Mechanisms.

Osteopontin in Bone Metabolism and Bone Diseases

Prognostic Significance of Osteopontin in Hepatitis B Virus-Related Hepatocellular Carcinoma

[Expression of Osteopontin Mrna and Its Protein in Colorectal Cancer and Liver Metastatic Tissues].

[Expression and Clinical Significance of Osteopontin in Colorectal Cancer and Liver Metastatic Tissues].

High-resolution Analysis of Genomic Profiles of Hepatocellular Carcinoma Cells with Different Osteopontin Expression

Expression of Osteopontin in Colonic Tissue of Patients with Inflammatory Bowel Disease

Osteopontin Regulates Interleukin-17 Production in Hepatitis

Osteopontin Enhanced Hepatic Metastasis of Colorectal Cancer Cells

Osteopontin As a Mediator of NKT Cell Function in T Cell-Mediated Liver Diseases.

High Expression of Osteopontin and Cd44v6 in Odontogenic Keratocysts

Expression of osteopontin in human endometrium throughout menstrual cycle

Biology of cancer and aging

Expression, roles, receptors, and regulation of osteopontin in the kidney

Osteopontin Takes Center Stage in Chronic Liver Disease

Abstract 2695: Osteopontin Regulated Epithelial-Mesenchymal Transition Via PI3K/AKT Signaling Pathway in Hepatocellular Carcinoma.

Effect of methylcarbonylmethyl 2(S)-[4-(4-guanidino-benzoyloxy)phenyl] propionate methanesulfonate (TT-S24) on experimental pancreatitis in rats.

Osteopontin Expression in Hepatocellular Carcinoma Cell Lines with Different Metastatic Potential and HCC Samples